Sanofi to seek approval of touted eczema drug despite mixed results biopharmadive.com Source link
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval Everyday Health Source link
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. BMS-986104 overview BMS-986104 is under development for the treatment of atopic […]
On Jan. 14, AbbVie‘s (NYSE:ABBV) Rinvoq received approval from the U.S. Food and Drug Administration (FDA) to treat adults and children at least 12 years old with moderate-to-severe atopic dermatitis (eczema) whose condition didn’t respond to other medicines. What led the FDA to approve Rinvoq for its third indication? And how much of a boost […]